Search results
Added:
3 years ago
Previously considered to be separate disease entities, the acute coronary syndromes (ACS) are somewhat arbitrarily divided on the basis of their electrocardiographic manifestations and are now thought to arise from a common disease process. Based on a number of factors, the severity of the ACS and, consequently, their attendant clinical risk may vary. The management of patients with ACS should…
View more
Added:
1 year ago
Added:
3 years ago
Acute coronary syndromes (ACS) are a major reason for death and morbidity in the industrialised world. One of the most successful treatments for ACS has been strategies to target the platelets and inhibit their function.
Mechanisms of Platelet Activation
Thrombus formation in the arteries is dependent on platelets and their ability to attach to the injured wall despite the rapid arterial blood…
View more
Added:
1 year ago
BCIS ACI 2023 – Dr Ziad Ali (St Francis Hospital & Heart Center, Roslyn, NY, US) summarises his ACI keynote lecture on intracoronary imaging in acute coronary syndromes. Dr Ali briefly discusses the FLAVOUR trial demonstrated that in patients with with intermediate coronary stenosis, FFR-guided PCI is noninferior to IVUS-guided PCI.
Recorded on-site BCIS ACI 2023, London.
View more
Added:
5 years ago
Diego Ardissino discusses PHARMCLO -Pharmacogenetics of Clopidogrel in Acute Coronary Syndromes.
Filmed by Radcliffe Cardiology on-site at the ACC 2018 congress in Orlando, US.
View more
Added:
3 years ago
Acute coronary syndromes (ACS) and acute pulmonary embolism (APE) are leading causes of hospital admission and mortality. Accurate risk stratification is important for both conditions to guide management and the use of therapies that lead to improved outcomes.
Acute Coronary Syndromes
Despite a steady decline in developed countries, ischaemic heart disease is still the leading cause of death…
View more
Added:
3 years ago
Abstract
The introduction of novel high-sensitivity cardiac troponin (hs-cTn) assays has made it possible to measure cardiac troponin levels that are up to 10-fold lower than those detectable by conventional cardiac troponin (cTn) assays. With such novel assays, an elevated risk of major adverse cardiovascular events was noted across the continuum of cTn levels, with an incremental risk of…
View more
Added:
7 months ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes.
Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation…
View more
B-type Natriuretic Peptides in the Management of Acute Heart Failure and Acute Coronary Syndromes
Added:
3 years ago
Article
Added:
3 years ago
Cardiovascular diseases are the leading cause of death in industrialised countries; among these, coronary artery disease (CAD) is the most prevalent and is associated not only with high mortality but also with substantial morbidity. Acute manifestations of CAD are ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), unstable angina pectoris (UAP) and sudden ischaemic death.1 Due to the…
View more
